Breast Cancer
From the Journals
Ten-year outcomes support skipping axillary lymph node dissection with positive sentinel nodes
Ten-year overall survival was 86.3% in the sentinel lymph node dissection group, compared with 83.6% in the axillary lymph node dissection group,...
Original Report
Assessing a multidisciplinary survivorship program in a group of predominantly Hispanic women with breast cancer
From the Editor
An ASCO 2017 recap: significant advances continue
From the Journals
Focus on lifestyle to manage menopause symptoms after breast cancer
Smoking cessation, weight loss and exercise, limiting alcohol intake, maintenance of adequate vitamin D and calcium levels, and a healthy diet...
News
FDA expands approval of fulvestrant for HR+/HER2– advanced breast cancer
The indication now includes fulvestrant as monotherapy for previously untreated women with HR+/HER2– advanced breast cancer.
From the Journals
Annual mammograms from age 40 linked with greatest reductions in mortality
Starting early and screening annually reduced the most deaths in the modeling study.
Community Translations
Ribociclib: another CDK inhibitor hits the mark in breast cancer
From the Journals
LIFSCREEN data support broader cancer screening in Li-Fraumeni syndrome
Of 23 new primary cancers found through screening in 20 patients, 10 belonged to the core LFS spectrum of breast cancer, sarcoma, and brain tumors...
News
FDA approves neratinib for extended adjuvant treatment of HER2+ breast cancer
A new approval may help keep HER2+ breast cancer from coming back.
Conference Coverage
Temporary tissue expanders optimize radiotherapy after mastectomy
LAS VEGAS – Radiation oncologists have found a new way to implement radiotherapy to mastectomy patients needing breast reconstruction.
From the Journals
Consequence of change? Medicaid disenrollment delayed breast cancer diagnosis
What’s the cost of rolling back Medicaid expansion?